ozempic semaglutide weight loss off-label FDA adds warning for intestinal blockage on Novo's Here's the GLP injectable lowdown

For instance, 15.8% of people taking a 0.5 mg injection experienced nausea, compared to 20.3% of people taking a 1.0 mg injection in clinical trials

This stepwise approach improves tolerability

Use syringes with attached needles (typically 29-31 gauge, 1/2 inch) for subcutaneous injection

Nausea incidence with GLP-1 therapies varies by agent, dose, and population, but current research indicates that roughly one in five to one in two users experience some nausea, most often during the first weeks of therapy

Regular check-ins with your healthcare provider ensure that the treatment remains effective and tailored to your ongoing needs